LobbyingCai Investments lobbying by quarter
Cai Investments's latest lobbying report covers Q2 2026, at $80K. Its first report covers Q2 2026; the issues it reports most are Budget/Appropriations and Chemicals/Chemical Industry.
Cai Investments
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $80K
- Last 2 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2026 | $80K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$10K · 1 reports
- Chemicals$10K · 1 reports
- Consumer protection and safety$10K · 1 reports
- Health issues$10K · 1 reports
- Manufacturing$10K · 1 reports
- Medical research and clinical labs$10K · 1 reports
- Medicare and Medicaid$10K · 1 reports
- Trade$10K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Forbes-Tate | $80K | 1 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Forbes-Tate | $80K |
| 04/08for Q2 | Forbes-Tate | Under $5,000 |